206 related articles for article (PubMed ID: 2947465)
1. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
Friedman M
Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
[TBL] [Abstract][Full Text] [Related]
3. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
[TBL] [Abstract][Full Text] [Related]
4. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
Ashutosh K; Lang H
Ann Allergy; 1984 Nov; 53(5):401-6. PubMed ID: 6238558
[TBL] [Abstract][Full Text] [Related]
5. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
LeDoux EJ; Morris JF; Temple WP; Duncan C
Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
[TBL] [Abstract][Full Text] [Related]
6. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Colice GL
Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
[TBL] [Abstract][Full Text] [Related]
7. Combination bronchodilator therapy in asthma.
Ruffin RE; McIntyre E; Crockett AJ; Zielonka K; Alpers JH
J Allergy Clin Immunol; 1982 Jan; 69(1 Pt 1):60-5. PubMed ID: 6459357
[TBL] [Abstract][Full Text] [Related]
8. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
Campbell S
Arch Intern Med; 1999 Jan; 159(2):156-60. PubMed ID: 9927098
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
Karpel JP
Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bronchodilator effects of Duovent and Reproterol in patients with chronic reversible airway obstruction.
Baronti A; Grieco A; Lelli M; Virgili G
Respiration; 1986; 50 Suppl 2():173-6. PubMed ID: 2951800
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
Karpel JP; Pesin J; Greenberg D; Gentry E
Chest; 1990 Oct; 98(4):835-9. PubMed ID: 2145136
[TBL] [Abstract][Full Text] [Related]
13. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
Weintraub SJ; Eschenbacher WL
Chest; 1989 Apr; 95(4):861-4. PubMed ID: 2522385
[TBL] [Abstract][Full Text] [Related]
14. Use of ipratropium bromide in asthma. Results of a multi-clinic study.
Storms WW; Bodman SF; Nathan RA; Busse WW; Bush RK; Falliers CJ; O'Hollaren JD; Weg JG
Am J Med; 1986 Nov; 81(5A):61-6. PubMed ID: 2947462
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the intensity and duration of the bronchodilatory action of fenoterol-ipratropium bromide in combination compared with terbutaline and placebo in patients with chronic obstructive lung disease.
Longhini E; Bozzoni M; Mastropasqua B; Marazzini L
Respiration; 1986; 50 Suppl 2():169-72. PubMed ID: 2951799
[TBL] [Abstract][Full Text] [Related]
16. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator.
Chervinsky P
J Allergy Clin Immunol; 1977 Jan; 59(1):22-30. PubMed ID: 137921
[TBL] [Abstract][Full Text] [Related]
17. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
[TBL] [Abstract][Full Text] [Related]
18. Ipratropium bromide.
Gross NJ
N Engl J Med; 1988 Aug; 319(8):486-94. PubMed ID: 2970009
[No Abstract] [Full Text] [Related]
19. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
[TBL] [Abstract][Full Text] [Related]
20. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.
Rebuck AS; Chapman KR; Abboud R; Pare PD; Kreisman H; Wolkove N; Vickerson F
Am J Med; 1987 Jan; 82(1):59-64. PubMed ID: 2879458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
